CME / CE - Physicians' Education Resource

16
Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in Trials
April 16, 2018
Chicago, IL
CME
2.0

21
Medical Crossfire®: Management of Adverse Events Associated with Therapies for Hematological Disorders: Nurses' Perspective
Expires on
Apr 21, 2018
CME
2.0

27
Community Practice Connections™: Oncology Best Practice™: Choosing Therapies for Patients with EGFR-mutant Lung Cancers: More Options... More Decisions... Better Outcomes
Expires on
Apr 27, 2018
CME
2.0
Community Practice Connections™: 21st Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma
Expires on
Apr 27, 2018
CME
2.0

28
Oncology Briefings™: Updates in Therapeutic Options and Approaches for Tenosynovial Giant Cell Tumors
Expires on
Apr 28, 2018
CME
1.0
Community Practice Connections™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations Across Lung, Head and Neck, and Bladder Cancers
Expires on
Apr 28, 2018
CME
2.0
Community Practice Connections™: 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
Expires on
Apr 28, 2018
CME
2.0
3rd Annual School of Gastrointestinal Oncology™ (SOGO®)
April 28, 2018
New York, NY

Customize

Quick Links

Why CME?

Europe

Specialties

2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
Physicians’ Education Resource ®, LLC.
All rights reserved.

All Activities

AML Year in Review™: Live Webcast Around the World

Faculty: Francesco Lo Coco, MD; Laura Cicconi, MD; Harry P. Erba, MD, PhD; Eytan M. Stein, MD

Expires on April 16, 2019

CNE: 2.0

CME: 2.0

Year in Review™: Reflecting on Recent Evidence With an Eye to the Future of Lung Cancer Management

Faculty: David R. Gandara, MD; Mark Kris, MD; Naiyer A. Rizvi, MD

Expires on March 30, 2019

CNE: 1.5

CME: 1.5

Community Practice Connections Cardiology Best Practice: Direct Acting Oral Anticoagulants (DOACs) and Reversal Agents: Updates for the Hospitalist

Faculty: Steven Deitelzweig, MD, MMM, SFHM, FACP, FACC, Charles V. Pollack, Jr, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP

Expires on March 30, 2019

CME: 1.0

Provider and Caregiver Connection™: Improving Outcomes in Idiopathic Pulmonary Fibrosis (IPF) Through a Patient-Centered, Team-Based Approach

Faculty: Stephen Brunton, MD, Louis Kuritzky, MD, Steven Nathan, MD, Mary M. Salvatore, MD, MBA

Expires on March 30, 2019

CME: 1.0

AANP: 1.0

Cancer Summaries and Commentaries™: Update from Atlanta – Advances in the Treatment of Acute Myeloid Leukemia

Faculty: Amir T. Fathi, MD, MSc

Expires on March 30, 2019

CME: 0.75

2017 Year in Review™: Clinical Impact of Immunotherapies in the Treatment of Cancer

Faculty: Naiyer A. Rizvi, MD; Ezra Cohen, MD, FRCPSC, FASCO; Susan F. Slovin, MD, PhD

Expires on March 30, 2019

CME: 1.75

Live Meetings

3rd Annual School of Gastrointestinal Oncology™ (SOGO®)

April 28, 2018
New York, NY

Venous Thromboembolism Prophylaxis in Hospitalized Adult Patients: A Multidisciplinary Approach

May 1-31, 2019

2nd Annual European Symposium on Lung Cancers™

May 4-5, 2018
Barcelona, Spain

Live Webcast: Virtual Current Trends™: Global Perspectives on Emerging Data in Hepatocellular Carcinoma

May 10, 2018
Live Webcast

CNE: 2.0

CME: 2.0

AJMC Accountable Care Delivery Congress

May 11, 2018
San Diego, California

CNE: 5.0

CME: 5.0

ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses

May 17, 2018
Washington, DC

CNE: 1.5

CME: 1.5

ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers

May 17, 2018
Washington, DC

CNE: 1.5

CME: 1.5

Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology Strategies

May 19, 2018
San Francisco, CA

CME: 2.0

Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of Car T-Cell Therapy in Hematologic Malignancies

May 24, 2018
Live Webcast

CME: 3.0

ASCO: PARP Inhibition in Breast Cancer: Practical Methods to Interpret and Apply the Evidence for Your Patients

June 1, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

ASCO: Medical Crossfire®: The Advent of CAR T-Cell Therapy for Lymphoid Malignancies and Beyond

June 1, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

ASCO: New Directions in Advanced Cutaneous Squamous Cell Carcinoma: Emerging Evidence of Immunotherapy

June 2, 2018
Chicago, IL

CNE: 0.0

CME: 2.0

ASCO: Matching Treatment to Patient in an Ever-Changing Era for the Management of Advanced Renal Cell Carcinoma: An Expert Tumor Board Discussion

June 2, 2018
Chicago, IL

CME: 2.0

ASCO: Medical Crossfire®: Evolving Applications for PARP Inhibitors in Ovarian Cancer: Building on a Solid Foundation

June 3, 2018
Chicago, IL

CNE: 2.0

CME: 2.0

2nd Annual International Congress on Oncology Pathology™: Towards Harmonization of Pathology and Oncology Standards

June 23, 2018
New York, NY

17th Annual International Congress on the Future of Breast Cancer® West

July 13-14, 2018
San Diego, CA

2nd Annual Live Medical Crossfire®: Hematologic Malignancies

July 14, 2018
New York, NY

19th Annual International Lung Cancer Congress®

July 26-28, 2018
Huntington Beach, CA

17th Annual International Congress on the Future of Breast Cancer® East

July 27-28, 2018
New York, NY

2nd Annual School of Nursing Oncology™

August 3-4, 2018
Chicago, IL

3rd Annual European Congress on Immunotherapies in Cancer™

21-22 September 2018
Barcelona, Spain

3rd Annual European Congress on Hematology™: Focus on Lymphoid Malignancies

12-13 October 2018
Paris, France

16th Annual School of Breast Oncology®

November 1-3, 2018
Atlanta, GA

36th Annual CFS®

November 7-9, 2018
New York, NY

13th Annual New York Lung Cancers Symposium

November 10, 2018
New York, NY

2nd Annual Paris Breast Cancer Conference

November 16-17, 2018
Paris, France

3rd Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

December 15, 2018
New York, NY

15th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 9, 2019
New York, NY

23rd Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas and Myeloma

February 28- March 3, 2019
Miami, FL

36th Annual Miami Breast Cancer Conference®

March 7-10, 2019
Miami, FL

37th Annual Miami Breast Cancer Conference®

March 5-8, 2020
Miami, FL